Last updated: July 23, 2026
Telcordia’s 2004 US patent litigation against Alcatel S.A. (and related defendants) under case number 1:04-cv-00874 maps to early-2000s telecom networking patent enforcement tied to broadband access and communications systems. The case is filed in the District of Delaware and proceeds through standard early phases (pleadings, claim construction activity, and dispositive motion practice). Public docket coverage identifies the case and core procedural posture but does not provide enough case-record content to produce a complete, reliable infringement/validity holding, trial outcome, or final settlement terms.
Because this request requires a litigation summary with substantive legal results and analysis, the response cannot be completed accurately with the information available here.
What patents were asserted in Telcordia Tech Inc. v. Alcatel S.A. 1:04-cv-00874?
Answer: Not determinable from the available record.
Patent list, asserted claims, and accused products
No asserted-patent identifiers, claim numbers, or accused systems/manufacturing configurations are available in the provided information. A litigation summary requires the patent list from the complaint or amended pleadings and the accused instrumentality mapping, which is not available in the present material.
When was Telcordia Tech Inc. v. Alcatel S.A. filed and what procedural milestones occurred (claim construction, motions, trial)?
Answer: Filing exists, but milestone outcomes cannot be confirmed from the available information.
Docket-level timeline elements that cannot be completed
A complete timeline requires, at minimum:
- Complaint filing date and parties
- Any amended complaints and added/removed defendants
- Markman/claim construction schedule and order dates
- Summary judgment motion dates and results
- Trial date(s), if any
- Final judgment and post-judgment orders
None of these dates or outcomes can be extracted from the currently provided record.
How did the court treat infringement and validity issues in 1:04-cv-00874?
Answer: No merits holding can be stated from the available information.
Infringement posture
A proper infringement analysis requires:
- Claim constructions
- Accused feature mapping
- Any infringement/non-infringement rulings
Those elements are not available.
Validity posture
A validity analysis requires:
- Prior art references and obviousness/anticipation theories
- Invalidity arguments and claim-by-claim conclusions
No such content is available.
Were there any settlements, consent judgments, or licensing outcomes in Telcordia v. Alcatel?
Answer: Not determinable from the available record.
Orange Book, FRAND, or cross-licenses
This case is a telecom patent dispute, not an FDA product exclusivity matter, but settlement/license outcomes still require docket orders or publicly reported deal terms. Those are not present.
What generic or biosimilar entry risks apply to this litigation (if any)?
Answer: None.
This dispute concerns patents covering telecommunications technologies, not drug products. Generic/biosimilar entry analysis is not applicable.
Which companies besides Alcatel were involved and how did the case caption evolve?
Answer: Not determinable from the available information.
A litigation summary typically includes:
- Full caption changes across amendments
- Consolidations or related cases
- Subsidiaries, parent companies, or successor entities
No caption evolution data is available.
How strong was Telcordia’s patent estate vs. Alcatel’s defenses in this case?
Answer: Not determinable from the available information.
Patent strength indicators missing
A strength analysis requires:
- Court-adopted claim scope (post-Markman)
- Prior art citations and validity survival
- Infringement comparisons against the accused products
None are available.
Key Takeaways
- The case identifier (1:04-cv-00874) and parties establish that Telcordia initiated a US patent action against Alcatel in 2004 in federal court.
- A complete litigation summary with merits outcome, asserted patents, and dispositive rulings cannot be produced accurately from the information available here.
- No generic or biosimilar entry implications apply because this is not drug/patient-medication litigation.
FAQs
- What district and case caption applies to Telcordia Tech Inc. v. Alcatel S.A. 1:04-cv-00874?
- How do I find the asserted patent list and claims for 1:04-cv-00874?
- Did the court issue claim construction (Markman) orders in Telcordia v. Alcatel?
- What dispositive motions (summary judgment or motions to dismiss) were filed in the case?
- Was there a settlement or final judgment in Telcordia v. Alcatel 1:04-cv-00874?
References
- Telcordia Tech Inc. v. Alcatel S.A., No. 1:04-cv-00874 (D. Del. filed 2004).
